Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement

BACKGROUND: The objective of this study was to investigate the efficacy of topical 0.1% tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement. METHODS: This prospective observational study included 1436 patients with refractory allergic conju...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Atsuki, Ohashi, Yuichi, Ebihara, Nobuyuki, Uchio, Eiichi, Okamoto, Shigeki, Kumagai, Naoki, Shoji, Jun, Takamura, Etsuko, Nakagawa, Yayoi, Namba, Kenichi, Fujishima, Hiroshi, Miyazaki, Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112440/
https://www.ncbi.nlm.nih.gov/pubmed/24695688
http://dx.doi.org/10.1136/bjophthalmol-2013-304453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112440/
https://www.ncbi.nlm.nih.gov/pubmed/24695688
http://dx.doi.org/10.1136/bjophthalmol-2013-304453

Ejemplares similares